| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
91,540,000 |
| Market
Cap: |
34.79(M) |
| Last
Volume: |
1,296,467 |
Avg
Vol: |
1,292,882 |
| 52
Week Range: |
$0.38 - $0.9341 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
| |
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Curis is a biotechnology company focused on the development of therapeutics for the treatment of cancer. Co.'s clinical stage drug candidates are: Emavusertib, which is being tested in a Phase 1/2 dose escalating clinical trial in patients with non-Hodgkin lymphomas; CI-8993, which is a monoclonal antibody; Fimepinostat, which is a small molecule that potently inhibits the activity of histone deacetylase, and phosphotidyl-inositol 3 kinase; CA-170, for which Co. has announced initial data from a clinical study in patients with mesothelioma in conjunction with the Society of lmmunotherapy of Cancer; and CA-327, which is a small molecule antagonist of PDL1 and TIM3.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-15 |
2023-11-14 |
2023-05-16 |
2022-05-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Mcnab James R |
Director |
– • – |
2013-08-16 |
4 |
B |
$4.00 |
$200,000 |
I/I |
50,000 |
250,000 |
2.1 |
- |
|
| Gray Michael |
CFO |
• – – |
2013-05-21 |
4 |
GD |
$0.00 |
$0 |
D/D |
6,000 |
97,304 |
|
- |
|
| Passeri Daniel R |
CEO and Director |
• – – |
2013-05-08 |
4 |
S |
$3.70 |
$321,352 |
D/D |
(86,852) |
198,898 |
|
- |
|
| Passeri Daniel R |
CEO and Director |
• – – |
2013-05-08 |
4 |
OE |
$2.43 |
$211,050 |
D/D |
86,852 |
285,750 |
|
- |
|
| Passeri Daniel R |
CEO and Director |
• – – |
2013-05-07 |
4 |
S |
$3.63 |
$145,200 |
D/D |
(40,000) |
198,898 |
|
- |
|
| Passeri Daniel R |
CEO and Director |
• – – |
2013-05-07 |
4 |
D |
$3.60 |
$360,000 |
D/D |
(100,000) |
238,898 |
|
- |
|
| Passeri Daniel R |
CEO and Director |
• – – |
2013-05-07 |
4 |
OE |
$2.43 |
$457,200 |
D/D |
188,148 |
338,898 |
|
- |
|
| Gray Michael |
CFO |
• – – |
2013-05-07 |
4 |
OE |
$2.43 |
$588 |
D/D |
242 |
103,304 |
|
- |
|
| Passeri Daniel R |
CEO and Director |
• – – |
2013-05-06 |
4/A |
S |
$3.66 |
$219,600 |
D/D |
(60,000) |
150,750 |
|
- |
|
| Passeri Daniel R |
CEO and Director |
• – – |
2013-05-06 |
4/A |
OE |
$2.43 |
$145,800 |
D/D |
60,000 |
210,750 |
|
- |
|
| Gray Michael |
CFO |
• – – |
2013-05-06 |
4 |
D |
$3.63 |
$120,912 |
D/D |
(33,309) |
103,062 |
|
- |
|
| Gray Michael |
CFO |
• – – |
2013-05-06 |
4 |
OE |
$2.43 |
$120,912 |
D/D |
49,758 |
136,371 |
|
- |
|
| Tobin James R |
Director |
– • – |
2013-05-06 |
4 |
D |
$3.63 |
$151,843 |
D/D |
(41,830) |
144,921 |
|
- |
|
| Tobin James R |
Director |
– • – |
2013-05-06 |
4 |
OE |
$2.43 |
$151,875 |
D/D |
62,500 |
186,751 |
|
- |
|
| Passeri Daniel R |
CEO and Director |
• – – |
2013-05-06 |
4 |
S |
$3.66 |
$219,600 |
D/D |
(60,000) |
218,417 |
|
- |
|
| Passeri Daniel R |
CEO and Director |
• – – |
2013-05-06 |
4 |
D |
$3.63 |
$490,050 |
D/D |
(135,000) |
278,417 |
|
- |
|
| Passeri Daniel R |
CEO and Director |
• – – |
2013-05-06 |
4 |
OE |
$2.43 |
$638,281 |
D/D |
262,667 |
413,417 |
|
- |
|
| Passeri Daniel R |
CEO and Director |
• – – |
2013-05-03 |
4 |
S |
$3.73 |
$242,450 |
D/D |
(65,000) |
150,750 |
|
- |
|
| Passeri Daniel R |
CEO and Director |
• – – |
2013-05-03 |
4 |
OE |
$2.43 |
$157,950 |
D/D |
65,000 |
215,750 |
|
- |
|
| Passeri Daniel R |
CEO and Director |
• – – |
2013-05-02 |
4 |
S |
$3.66 |
$183,000 |
D/D |
(50,000) |
150,750 |
|
- |
|
| Passeri Daniel R |
CEO and Director |
• – – |
2013-05-02 |
4 |
OE |
$2.43 |
$121,500 |
D/D |
50,000 |
200,750 |
|
- |
|
| Noel Mark |
VP, Tech Management |
• – – |
2013-05-02 |
4 |
S |
$3.66 |
$256,200 |
D/D |
(70,000) |
27,540 |
|
- |
|
| Noel Mark |
VP, Tech Management |
• – – |
2013-05-02 |
4 |
OE |
$2.43 |
$170,100 |
D/D |
70,000 |
45,282 |
|
- |
|
| Greenacre Martyn D |
Director |
– • – |
2013-05-02 |
4 |
S |
$3.67 |
$220,200 |
D/D |
(60,000) |
35,138 |
|
- |
|
| Greenacre Martyn D |
Director |
– • – |
2013-05-02 |
4 |
OE |
$1.09 |
$65,400 |
D/D |
60,000 |
95,138 |
|
- |
|
303 Records found
|
|
Page 4 of 13 |
|
|
